Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA. 2020;323:844–53.
2. Mitchell AP, Trivedi NU, Gennarelli RL, Chimonas S, Tabatabai SM, Goldberg J, et al. Are financial payments from the pharmaceutical industry associated with physician prescribing? A systematic review. Ann Intern Med. 2020;174:353–361.
3. Japan Pharmaceutical Manufacturers Association. Data Book 2021 Online. 2021. https://www.jpma.or.jp/news_room/issue/databook/2021_en/lofurc0000004we3-att/DB2021_en_full.pdf.
4. Inoue K, Blumenthal DM, Elashoff D, Tsugawa Y. Association between physician characteristics and payments from industry in 2015–2017: observational study. BMJ Open. 2019;9:e031010.
5. Marshall DC, Moy B, Jackson ME, Mackey TK, Hattangadi-Gluth JA. Distribution and patterns of industry-related payments to oncologists in 2014. JNCI. 2016;108:djw163.